Medical Condition

Compelling evidence reframes Alzheimer’s Disease as an immune-triggered neurodegenerative disorder linked to infections and brain-barrier dysfunction. By linking pathogen entry, blood-brain barrier dysfunction, and microglial activation to neurodegeneration, researchers can focus on new avenues for diagnostics and immunomodulatory treatment strategies for diseases such as Alzheimer’s.